Company intelligence / Profile preview

Pheiron

Ownership: Private
Employees: ~2
Development stage: Preclinical

Overview

Pheiron has developed an advanced AI-native platform, PheironGPS, that integrates large-scale human genetic and phenotypic data to identify causal links between therapeutic targets and diseases. The technology aims to improve drug development success rates by providing robust human evidence for target selection and patient stratification. Clinical results are reported through partner programs rather than proprietary assets. In collaboration with Ribocure Pharmaceuticals/Ribo Life Science Ltd., the platform has been used to advance RNA-based therapeutics in cardiometabolic diseases.

Therapeutic areas: OtherCardiovascular
Modalities: RNA therapeutics (siRNA)biomarker discoverytarget identification
Industry: Drug Discovery Services

Partnerships

Ribocure Pharmaceuticals AB / Suzhou Ribo Life Science Ltd. – strategic collaboration on AI-assisted drug development for RNA therapeutics targeting cardiometabolic diseases

Beyond the preview

Go deeper on Pheiron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pheiron.

Explore the full profile